Advanced Filters
noise

Heart Disease Clinical Trials

A listing of Heart Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,908 clinical trials
S Simone longhi, MD

Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis

observational epidemiological study of patients affected by systemic amyloidosis

18 - 99 years of age All Phase N/A
B Bavana Rangan, BDS, MPH

Progress Bifurcation Global Registry

Coronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions remain some of the most challenging, both in …

18 years of age All Phase N/A
M Masset Lea, BSc

Percutaneous Coronary Intervention Registry FRIBOURG

The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital & university Fribourg.

17 - 120 years of age All Phase N/A

Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

ARB-PMCF is a multicenter, observational study of the safety and performance of Abbott annuloplasty devices used in surgical repair of mitral and tricuspid valve regurgitation. The devices included in this study are the SJM™ Rigid Saddle Ring and SJM Séguin Annuloplasty Ring, indicated for mitral valve repair, and the SJM …

18 years of age All Phase N/A
K Kim M Williams, MPH

Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.

Information gathered from the patients via a disease specific questionnaire will be married to data from the National Cardiovascular Data Registry (NCDR®). Details will be continuously analyzed and used to direct quality of care at our center. The institution is categorized as a low-volume institution for percutaneous coronary intervention (PCI) …

18 years of age All Phase N/A
J Je Hwan Won, MD

Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

The purpose of this observational study is to evaluate the long-term effectiveness and safety of the OSFIT drug-eluting stent designed to facilitate procedures in coronary artery lesions. Additionally, the study aims to verify the accuracy of stent placement in the lesion of interest using Optical Coherence Tomography (OCT) among subgroups …

19 years of age All Phase N/A
J Joo-Yong Hahn, MD

Prospective Pecutaneous Coronary Intervention Registry

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, …

19 years of age All Phase N/A
N Natalija Odanovic, MD

Dedinje FFR/QFR Registry

Quantitative Flow Ratio (QFR) has shown good diagnostic performance against Fractional Flow Reserve (FFR) in several meta-analyses, comparable or even superior to nonhyperemic pressure ratios. However, the reproducibility of QFR is modest and there is high interand intra-observer variability even when fairly experienced but non-core lab operators (at least 150 …

18 years of age All Phase N/A
Y Yen-Wen Wu, MD, PhD

A Multi-center Cardiac PYP Scan Registry in Taiwan

Amyloid deposition in the heart is called cardiac amyloidosis (CA); 95% is immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR). Hereditary (ATTRm) or wild-type (ATTRwt) depends on whether the ATTRm gene is mutated or not. The most common mutation in Taiwan is A97S, 80% have left ventricular hypertrophy. The …

20 years of age All Phase N/A
H Hein Heidbuchel, MD, PhD

Lifetime Endurance Exercise to Prevent Coronary Artery Disease

The primary objective of the Master@Heart Trial is to investigate whether lifelong endurance exercise reduces the incidence of non-calcified plaques (both mixed and soft plaques) as compared to late-onset endurance exercise and a non-athletic lifestyle.

45 - 70 years of age Male Phase N/A

Simplify language using AI